Bone News and Research

RSS

Genta announces Phase 3 trial results of Genasense

Genta Incorporated today announced preliminary results from AGENDA, the Company’s Phase 3 trial of Genasense® (oblimersen sodium) Injection in patients with advanced melanoma. AGENDA is a randomized, double-blind, placebo-controlled trial of dacarbazine (DTIC) administered with or without Genasense® in patients who have not previously received chemotherapy.

16 Nov 2009

SANUWAVE Health reports financial results for the three months ended September 30, 2009

SANUWAVE Health, Inc.,, an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, reports its achievements and financial results for the three and nine months ended September 30, 2009.

16 Nov 2009

Bullseye Anatomic Cruciate Reconstruction System released

CONMED Corporation's CONMED Linvatec arthroscopy unit today announced the release of the Bullseye™ Anatomic Cruciate Reconstruction System, a novel guide system for anatomic cruciate ligament (ACL and PCL) reconstructions of the knee.

16 Nov 2009

UT physicians treat Iraqi girl with myasthenia gravis

Plagued by a growing weakness that left her unable to walk, talk and even take a normal breath, 11-year-old Iraqi Aram Ali was a shell of the bright little girl she used to be.

16 Nov 2009

Effects of vitamin D deficiency amplified by lower levels of sex hormone estrogen

Researchers at Johns Hopkins are reporting what is believed to be the first conclusive evidence in men that the long-term ill effects of vitamin D deficiency are amplified by lower levels of the key sex hormone estrogen, but not testosterone.

16 Nov 2009

Two units of UCB reduce risk of leukemia from returning, shows new study

A new study from the Masonic Cancer Center, University of Minnesota shows that patients who have acute leukemia and are transplanted with two units of umbilical cord blood (UCB) have significantly reduced risk of the disease returning.

16 Nov 2009

Misonix inks a three-year distribution agreement with Xenith in Dubai

Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has entered into a new, three year distribution agreement with Xenith, LLC, based in Dubai, UAE, for the distribution of the SonaStar(TM) Ultrasonic Surgical Aspirator, the BoneScalpel(TM) Ultrasonic Bone Cutter, and the SonicOne® Ultrasonic Wound Debrider.

13 Nov 2009

Improved method of chest closure may set new standard of care for open-heart surgery

An innovative method is being used to repair the breastbone after it is intentionally broken to provide access to the heart during open-heart surgery. The technique uses a state-of-the-art adhesive that rapidly bonds to bone and accelerates the recovery process.

13 Nov 2009

$Post-menopausal women in Asia hospitalized with fragility fracture are not aware whether they had osteoporosis or not$

Post-menopausal women in Asia hospitalized with fragility fracture are not aware whether they had osteoporosis or not

New results from a survey of 1,122 post-menopausal women in Asia found that nearly half (48.5 percent) were not aware whether or not they had osteoporosis despite being hospitalized with a fragility fracture.

13 Nov 2009

Orthopedic surgeon specializes in cutting-edge shoulder procedures from a 45-minute technique

Orthopedic surgeon, Dr. Corey G. Solman specializes in cutting-edge shoulder procedures including everything from a 45-minute technique called shoulder resurfacing to a reversed shoulder replacement that relieves pain, restores shoulder function and improves range of motion.

13 Nov 2009

Root canal treatment: Pennsylvania Dental Association answers patients' questions

You're visiting the dentist for what you think is a routine checkup and cleaning when he or she says you need a root canal. Though it's a term you've probably heard before, now that you're the one in the chair, you may have several questions and feel apprehensive about your upcoming procedure.

13 Nov 2009

Scientists to develop a treatment for rare genetic disorder, FOP

An international team of scientists, led by researchers at the University of Pennsylvania School of Medicine, is taking the first step in developing a treatment for a rare genetic disorder called fibrodysplasia ossificans progressiva (FOP), in which the body's skeletal muscles and soft connective tissue turns to bone, immobilizing patients over a lifetime with a second skeleton.

13 Nov 2009

Galapagos third quarter 2009 financial results in line with management expectations

Galapagos NV announces today that third quarter 2009 operational and financial results were in line with management expectations. These results encourage the Company to retain full year guidance of EUR 100 million revenues, a growth of 30% compared to 2008. Galapagos' service division BioFocus will significantly increase its cash contribution to the Group result for the full year 2009.

13 Nov 2009

Varian and SSI sign reseller's agreement

Varian, Inc. announced today that Steady State Imaging (SSI) has signed a reseller's agreement with Varian, Inc. regarding SSI's new SWIFT Software for Varian's research MRI Systems. SWIFT is a novel MRI technology that advances existing MR techniques with the ability to silently image structures and tissues previously invisible to conventional MRI systems.

13 Nov 2009

Updated efficacy results from Allos Therapeutics' FOLOTYN study to be presented at the ASH meeting

Allos Therapeutics, Inc. today announced that abstracts from studies of FOLOTYN™ (pralatrexate injection) were accepted for presentation at the 51st Annual Meeting of the American Society of Hematology (ASH) to be held at the Ernest N. Morial Convention Center in New Orleans, La., from December 5-8, 2009.

12 Nov 2009

Data supports the use of ExAblate as a safe, effective and durable treatment for uterine fibroids

InSightec Ltd. today announced that three new papers published in the November issue of Ultrasound in Obstetrics and Gynecology add to the growing body of data supporting the use of ExAblate(R) as a safe, effective and durable treatment for uterine fibroids.

12 Nov 2009

New, flexible scaffold for multi-level posterolateral fusion procedures

Medtronic, Inc. today announced the full U.S. market release of MASTERGRAFT® Strip – a new, highly flexible ceramic scaffold intended for use in combination with a patient’s own bone for fusing multiple levels of the posterolateral spine.

11 Nov 2009

TGA approves OrthoAccel Technologies' application to market AcceleDent System in Australia

OrthoAccel Technologies, Inc., developers of the AcceleDent System, which is an acceleration device to enhance orthodontics, announced that its application to market and distribute the product for sale was approved by Australia's Therapeutic Goods Administration (TGA). AcceleDent is classified as an, "orthodontic appliance system," in Australia.

11 Nov 2009

Osteotech highlights Magnifuse bone grafting products at NASS Annual Meeting

Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, today announced it is highlighting three procedure-specific MagniFuse(TM) bone grafting products for different spine therapy areas at the North American Spine Society (NASS) 2009 Annual Meeting, taking place November 10th through 14th in San Francisco, California. To date MagniFuse has been used in 40 spinal surgeries in the United States

11 Nov 2009

Laser Spine Institute opens new medical center in Philadelphia

After helping thousands of patients get their lives back through minimally invasive endoscopic spinal surgery at their facilities in Tampa and Scottsdale, the Laser Spine Institute announces the opening of a new medical center in Philadelphia.

11 Nov 2009

Bone News and Research

Genta announces Phase 3 trial results of Genasense

SANUWAVE Health reports financial results for the three months ended September 30, 2009

Bullseye Anatomic Cruciate Reconstruction System released

UT physicians treat Iraqi girl with myasthenia gravis

Effects of vitamin D deficiency amplified by lower levels of sex hormone estrogen

Two units of UCB reduce risk of leukemia from returning, shows new study

Misonix inks a three-year distribution agreement with Xenith in Dubai

Improved method of chest closure may set new standard of care for open-heart surgery

Post-menopausal women in Asia hospitalized with fragility fracture are not aware whether they had osteoporosis or not

Orthopedic surgeon specializes in cutting-edge shoulder procedures from a 45-minute technique

Root canal treatment: Pennsylvania Dental Association answers patients' questions

Scientists to develop a treatment for rare genetic disorder, FOP

Galapagos third quarter 2009 financial results in line with management expectations

Varian and SSI sign reseller's agreement

Updated efficacy results from Allos Therapeutics' FOLOTYN study to be presented at the ASH meeting

Data supports the use of ExAblate as a safe, effective and durable treatment for uterine fibroids

New, flexible scaffold for multi-level posterolateral fusion procedures

TGA approves OrthoAccel Technologies' application to market AcceleDent System in Australia

Osteotech highlights Magnifuse bone grafting products at NASS Annual Meeting

Laser Spine Institute opens new medical center in Philadelphia

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News